M. Yamasaki

Significant role of host sialylated glycans in the infection and spread of severe acute respiratory syndrome coronavirus 2

M. Muramatsu, S. Fukushi, M. Takeda, 2022, PLoS pathogens.

Serodiagnosis of hepatitis C virus infection by ELISA for antibodies against the putative core protein (p20c) expressed in Escherichia coli.

M. Yamasaki, H. Okamoto, F. Tsuda, 1992, Journal of immunological methods.

Mefloquine, a Potent Anti-severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Drug as an Entry Inhibitor in vitro

M. Muramatsu, S. Aoki, S. Fukushi, 2021, Frontiers in Microbiology.

Anti-severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) potency of Mefloquine as an entry inhibitor in vitro

M. Muramatsu, S. Aoki, S. Fukushi, 2020, bioRxiv.

Identification of Anti-Severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Oxysterol Derivatives In Vitro

M. Muramatsu, F. Parhami, T. Wakita, 2021, bioRxiv.

Chimeric hepatitis B virus core particles with parts or copies of the hepatitis C virus core protein

H. Okamoto, Y. Miyakawa, A. Yoshikawa, 1993, Journal of virology.

Fungal Secondary Metabolite Exophillic Acid Selectively Inhibits the Entry of Hepatitis B and D Viruses

M. Muramatsu, Yukihiro Asami, C. Sureau, 2022, Viruses.

Synthesis and Antiviral Activities of Neoechinulin B and Its Derivatives

Kazane Nishioka, K. Watashi, K. Kuramochi, 2021, Journal of Natural Products.